DEF: MediaAlpha Sets 2026 Annual Meeting, Board Elections
Definitive Proxy Statement
MediaAlpha, Inc. announces its 2026 Annual Meeting of Stockholders to elect Class III directors and ratify PricewaterhouseCoopers LLP as its independent auditor, alongside a review of 2025 financial performance.
Summary
- The 2026 Annual Meeting of Stockholders will be held virtually on Tuesday, May 5, 2026, at 10:00 a.m. Pacific Time.
- Stockholders will vote on the election of two Class III director nominees, Venmal (Raji) Arasu and Kathy Vrabeck, to serve until the 2029 annual meeting.
- Stockholders will also vote on the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
- Lara Sweet will not stand for re-election as a Class III director for personal reasons, with her service terminating on the date of the Annual Meeting.
- For fiscal year 2025, the company achieved a Total Transaction Value of $2.2 billion, a 45% year-over-year increase, and Net Income of $26.8 million, up 21% year-over-year.
- Adjusted EBITDA for 2025 reached $113.7 million, an 18% year-over-year increase, marking the first time the company crossed the $1 billion Revenue and $100 million Adjusted EBITDA milestones.
- The P&C insurance vertical's Transaction Value increased 65% year-over-year to $1.9 billion.
- Revenue from the Health insurance vertical declined due to scaling back the under-65 health sub-vertical and ongoing industry-wide headwinds in Medicare.
- Executive officers received annual incentive bonus payouts equal to 123.4% of their target incentive for 2025, based on a blend of Transaction Value and Adjusted EBITDA performance.
- For fiscal 2026, 25% of executive officers' long-term incentive compensation will be in performance share units (PRSUs) tied to three-year Adjusted EBITDA goals, with the remaining 75% as time-based RSUs.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this filing as moderately positive, reflecting strong growth in core business segments and proactive corporate governance, despite challenges in the health vertical and ongoing regulatory scrutiny.
Positives
- Total Transaction Value increased by 45% year-over-year to $2.2 billion, exceeding the 2025 target of $1.89 billion.
- Net income increased by 21% year-over-year to $26.8 million.
- Adjusted EBITDA increased by 18% year-over-year to $113.7 million, marking a significant milestone.
- Transaction Value from the P&C insurance vertical showed robust growth, increasing 65% year-over-year to $1.9 billion.
- The company continued to expand relationships with key supply and demand partners.
- The Board composition is strong, with 71% independent directors, 43% women, and 43% racially and/or ethnically diverse members.
- All Board committees are chaired by women and comprised solely of independent directors, indicating strong corporate governance.
- Stockholders approved the 2025 executive compensation on a non-binding advisory basis with approximately 90% of votes cast in favor.
- The adoption of a Deferred Share Unit Subplan allows directors and senior management to defer RSU awards, offering flexibility and aligning long-term interests.
- The company is pursuing an initiative to assess environmental and governance practices, including greenhouse gas emissions and climate-related financial risks, demonstrating a commitment to sustainability.
Negatives
- Revenue from the Health insurance vertical declined due to the decision to scale back the under-65 health sub-vertical and ongoing industry-wide headwinds within Medicare due to high carrier loss ratios.
- The ongoing FTC enforcement action has a potential for an 'as-yet-undetermined but significant impact' on the company's under-65 health business and its future operating results.
- Legal expenses for the year ended December 31, 2025, included an increase of $38.0 million to the loss reserve established in connection with the FTC Matter.
- A write-off of intangible assets totaling $13.416 million occurred in 2025, related to the acquisition of Customer Helper Team, LLC.
- Adjusted EBITDA of $114.0 million for 2025 was below the target of $122.4 million for the annual incentive bonus plan, although overall payout was above target due to strong Transaction Value.
Risks
- The ongoing FTC enforcement action poses a significant, though currently undetermined, risk to the company's under-65 health business and future operating results.
- Payments under the tax receivables agreement could be substantial and may exceed the actual cash tax benefits realized, potentially impacting liquidity.
- There is a risk that the IRS could successfully challenge tax basis increases, leading to non-reimbursement for prior payments made under the tax receivables agreement.
- If QL Holdings LLC were treated as a publicly traded partnership for U.S. federal income tax purposes, it would be subject to entity-level tax on its taxable income.
- The company faces risks related to attracting and retaining top-level talent in a competitive market, which its compensation program aims to mitigate.
Future Outlook
The company aims to continue growing its business in a sustainable and socially responsible manner, with a focus on long-term value creation for shareholders. For fiscal 2026, a portion of long-term incentive compensation for executive officers will be in performance share units tied to three-year Adjusted EBITDA goals, reflecting an intent to further align executive compensation with long-term financial performance. The company will also continue to assess its environmental and governance related practices and disclosures, including biennial assessments of climate-related financial risks.
Management Comments
- We are committed to fostering, cultivating, and maintaining a culture of equal opportunity.
- Our philosophy and actions are built on the premise that as an employer and citizens of our communities, we can create opportunities for lasting change.
- Our core values speak to the importance of individuality, transparency, and challenging ourselves to actively learn and grow together.
- As we look ahead, we will continue to assess our company practices with the intent of creating sustainable programs over the long-term.
Industry Context
StockSavvy.ai notes that MediaAlpha's strong growth in the P&C insurance vertical, with a 65% increase in Transaction Value, indicates robust performance in a key segment, potentially outperforming some competitors facing broader market challenges. The decline in the Health insurance vertical, particularly due to 'industry-wide headwinds within Medicare due to high carrier loss ratios' and the scaling back of the under-65 sub-vertical, reflects a broader trend of regulatory and market pressures impacting health insurance lead generation and advertising. The company's move to incorporate performance share units tied to Adjusted EBITDA for executive compensation in 2026 aligns with a growing industry trend of linking executive pay more directly to long-term financial performance and shareholder value, especially as companies mature post-IPO.
Comparison to Industry Standards
- MediaAlpha's 2025 Adjusted EBITDA growth of 18% to $113.7 million, and 55% excluding under-65 health, suggests strong operational efficiency and growth compared to many digital advertising and lead generation platforms that may be experiencing slower growth or increased competition.
- The company's P&C insurance vertical Transaction Value growth of 65% to $1.9 billion indicates robust market penetration and demand, potentially outpacing competitors focused on more saturated or challenged verticals.
- The continued appointment of PricewaterhouseCoopers LLP, a Big Four accounting firm, as its independent auditor since 2017, aligns with best practices for public companies in terms of audit quality and financial oversight.
- The board composition, with 71% independent directors, 43% women, and 43% racially/ethnically diverse members, exceeds diversity benchmarks for many public companies, demonstrating a commitment to modern corporate governance standards.
- The CEO to median employee pay ratio of 28-to-1 is within the typical range for publicly traded companies, though comparisons vary widely by industry and company size.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Class III Director | Lara Sweet | NA | May 5, 2026 | Will not stand for re-election for personal reasons. |
| Chief Technology Officer | Eugene Nonko | Amy Yeh | July 2025 | Eugene Nonko stepped down to serve as Chief Architect and director; Amy Yeh was promoted from Senior Vice President, Technology. |
| Chief Revenue Officer | NA | Keith Cramer | February 2025 | Promoted from Senior Vice President, Supply Partnerships. |
| Chief Architect | NA | Eugene Nonko | June 2025 | Stepped down as Chief Technology Officer to serve in a non-executive capacity as Chief Architect and director. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Director Compensation Policy Revision | Approved increases to the annual cash retainer ($50,000), annual equity award ($200,000 in RSUs), and annual retainer for the chairperson of the Board of Directors ($60,000), along with committee chair/member retainers, based on a competitive market analysis. | 2025 | Aims to align director compensation with market pay levels among peer companies and attract/retain qualified directors. |
| Deferred Share Unit Subplan Adoption | Approved a Subplan under the 2020 Omnibus Incentive Plan, allowing Board members and eligible senior management to elect to defer timeand performance-based RSU awards. | November 2025 | Provides flexibility for directors and senior management in managing equity compensation and aligns interests with long-term shareholder value. |
| Executive Compensation Structure Change | For fiscal 2026, 25% of NEO long-term incentive value will be granted as performance share units (PRSUs) tied to three-year Adjusted EBITDA goals, with the remaining 75% granted as time-based RSUs. | Fiscal Year 2026 | Further aligns executive compensation with the company's long-term financial performance and shareholder interests, introducing performance-based equity awards. |
| Stock Ownership Guidelines | Adopted guidelines requiring non-employee directors to own MediaAlpha stock valued at least five times their annual cash retainer, the CEO six times annual base salary, the CFO three times, and other executive officers two times. Requires retention of 75% of net shares from equity awards until guidelines are met. | NA (already adopted) | Enhances alignment of interests between directors, executive officers, and shareholders, promoting a long-term perspective. |
| Corporate Responsibility Initiative | Pursuing an initiative to assess environmental and governance practices and disclosures, identify priorities, and develop action plans. This includes an assessment of Scope 1, 2, and 3 greenhouse gas emissions and climate-related financial risks (TCFD-aligned). | Ongoing | Demonstrates commitment to sustainable and socially responsible business practices, enhancing the ESG profile and potentially mitigating long-term risks. |
Legal Proceedings
- An ongoing FTC enforcement action has a potential for an 'as-yet-undetermined but significant impact' on the company's under-65 health business and its future operating results.
- Legal expenses for the year ended December 31, 2025, include an increase of $38.0 million to the loss reserve established in connection with the FTC Matter.
Related Party Transactions
- The Fourth Amended and Restated Limited Liability Company Agreement of QL Holdings LLC governs the operations of QL Holdings LLC, where MediaAlpha, Inc. (through Intermediate Holdco) is the sole managing member. It allocates net profits/losses and distributions approximately 87.1% to MediaAlpha and 12.9% to Class B-1 Unit Holders (including Mr. Yi, OBF Investments, LLC, O.N.E. Holdings LLC, and certain employees).
- The Exchange Agreement allows holders of Class B-1 units (including Insignia and certain Class B-1 Unit Holders) to exchange one Class B-1 unit and one Class B common stock share for one Class A common stock share (or cash at MediaAlpha's election).
- The Tax Receivables Agreement (TRA) requires MediaAlpha to pay Insignia, certain Class B-1 Unit Holders, and White Mountains 85% of cash tax savings realized from tax basis increases (due to IPO purchases, post-IPO exchanges, and Pre-IPO Leveraged Distribution) and utilization of Intermediate Holdco's net operating losses. A hypothetical payment of approximately $163 million is estimated if all Class B-1 units were acquired on December 31, 2025.
- The Registration Rights Agreement grants White Mountains and certain Class B-1 Unit Holders demand, shelf, and piggyback registration rights for shares of Class A common stock.
- The Stockholders Agreement with White Mountains, Insignia, and the Founders governs Board composition (nomination rights for White Mountains and Founders), committee composition, and corporate governance. It includes voting agreements for Board nominees and a waiver of the corporate opportunity doctrine.
- On September 3, 2025, MediaAlpha repurchased 3,234,894 shares of Class A common stock from Insignia at $10.17 per share, for an aggregate purchase price of approximately $32.9 million. Following this Share Repurchase, Insignia no longer beneficially owns any shares of common stock of the company.
Stakeholder Impact
- Shareholders: Potential for increased long-term value through strategic growth and improved corporate governance. Risks include potential dilution from equity awards and negative impacts from the FTC action or TRA payments.
- Employees: Participation in 401(k) plan, eligibility for equity-based compensation, and potential for deferred share units. Changes in executive roles and responsibilities, such as promotions and transitions.
- Customers/Partners: Continued expansion of relationships with key supply and demand partners, particularly in the P&C insurance vertical.
- Regulatory Authorities: Ongoing engagement with the FTC regarding the enforcement action and adherence to SEC and NYSE rules and regulations.
Next Steps
- Elect two Class III director nominees (Venmal (Raji) Arasu and Kathy Vrabeck) at the 2026 Annual Meeting.
- Ratify the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026.
- Continue to evaluate the executive compensation program, including potential refinements to the long-term incentive mix or performance measurement structure in future years.
- Conduct biennial assessments of climate-related financial risks as required by California law.
- Publish final voting results of the Annual Meeting in a Current Report on Form 8-K within four business days.
- Receive stockholder proposals for the 2027 Annual Meeting by November 23, 2026 (under Rule 14a-8) or between January 5, 2027, and February 4, 2027 (under by-laws).
Key Dates
| Date | Description |
|---|---|
| 2020-10-27 | Date of stockholders agreement with White Mountains Investments (Luxembourg) S. r.l., Insignia QL Holdings, LLC, Insignia A QL Holdings, LLC, Steven Yi, and Eugene Nonko. |
| 2020-12-31 | Fixed investment date for TSR calculation in Pay-versus-Performance table. |
| 2021-03-18 | SEC declared effective the registration statement on Form S-1 (File No. 333-254338) for IPO reorganization. |
| 2021-05-01 | Jeffrey Coyne joined as General Counsel and Secretary. |
| 2021-11-01 | Patrick Thompson joined as Chief Financial Officer. |
| 2021-12-31 | End of fiscal year 2021 for financial metrics. |
| 2022-12-31 | End of fiscal year 2022 for financial metrics. |
| 2023-08-01 | Compensation Committee adopted Incentive-Based Compensation Recovery Policy. |
| 2023-09-15 | Effective date for amended employment agreements for Messrs. Yi and Nonko to receive base salaries in cash and RSU awards. |
| 2023-10-01 | TRA amended to use blended state tax rate and SOFR as interest rate benchmark. |
| 2023-10-01 | Lara Sweet joined Entravision Communications Corporation board. |
| 2023-11-01 | Kathy Vrabeck joined Medicine Man Technologies, Inc. board. |
| 2023-12-01 | Ramon Jones joined Pubmatic, Inc. board. |
| 2023-12-15 | Grant date for Salary RSU Awards for Messrs. Yi and Nonko for period ending March 14, 2024. |
| 2023-12-31 | End of fiscal year 2023 for financial metrics. |
| 2024-03-15 | Grant date for Salary RSU Awards for Messrs. Yi and Nonko for period ending June 14, 2024. |
| 2024-05-15 | Compensation Committee approved amendments to employment agreements with Messrs. Yi and Nonko to resume cash payment of base salaries after June 15, 2024. |
| 2024-06-15 | Effective date for Messrs. Yi and Nonko to resume cash payment of base salaries. |
| 2024-11-18 | Original due date for Mr. Coyne's Form 4 report related to shares withheld for tax obligations. |
| 2024-11-20 | Mr. Coyne's Form 4 report related to shares withheld for tax obligations was filed late. |
| 2024-12-31 | End of fiscal year 2024 for financial metrics. |
| 2025-02-01 | Keith Cramer appointed Chief Revenue Officer. |
| 2025-02-04 | Compensation Committee approved amendments to employment agreements with Messrs. Yi and Nonko to resume cash payment of annual incentive bonuses for Mr. Yi and remove eligibility for Mr. Nonko for 2025. |
| 2025-03-01 | Bradley Hunt appointed director. |
| 2025-03-15 | Grant date for annual time-based RSU awards to NEOs for 2025. |
| 2025-05-14 | Date of 2025 annual meeting of stockholders where executive compensation was approved. |
| 2025-05-14 | Grant date for annual RSU award of 23,100 RSUs to Ms. Arasu, Mr. Hunt, Ms. Sweet, and Ms. Vrabeck. |
| 2025-05-15 | Commencement of quarterly vesting for annual RSUs granted to NEOs in March 2025. |
| 2025-06-01 | Eugene Nonko stepped down as Chief Technology Officer and remained as a director. |
| 2025-06-01 | Compensation Committee approved additional amendments to Mr. Nonko's employment agreement relating to his annual incentive bonus plan for fiscal 2025. |
| 2025-07-01 | Amy Yeh appointed Chief Technology Officer. |
| 2025-07-15 | Grant date for additional RSU grant to Mr. Nonko. |
| 2025-08-15 | Commencement of quarterly vesting for additional RSUs granted to Mr. Nonko in July 2025. |
| 2025-09-03 | Agreement date for share repurchase with Insignia. |
| 2025-09-04 | Closing date for share repurchase with Insignia. |
| 2025-11-01 | Ramon Jones appointed director. |
| 2025-11-01 | Board of Directors approved Deferred Share Unit Subplan. |
| 2025-11-14 | Grant date for prorated annual RSU grant of 7,250 RSUs to Mr. Jones. |
| 2025-12-01 | Ms. Vrabeck and Mr. Hunt elected to defer a portion of their 2025 annual RSU awards and all of their 2026 annual RSU awards. |
| 2025-12-31 | End of fiscal year 2025 for financial metrics. |
| 2026-03-11 | Record date for determining stockholders entitled to vote at the 2026 Annual Meeting. |
| 2026-03-16 | Lara Sweet notified the Board she would not stand for re-election. |
| 2026-03-23 | Date of proxy statement distribution and posting. |
| 2026-05-03 | Registration deadline for 2026 Annual Meeting (5:00 p.m. Eastern Time). |
| 2026-05-04 | Deadline to revoke proxy by written notice (no later than). |
| 2026-05-05 | Date of 2026 Annual Meeting of Stockholders (10:00 a.m. Pacific Time). |
| 2026-11-23 | Deadline for stockholder proposals under Rule 14a-8 for 2027 Annual Meeting proxy statement. |
| 2027-01-05 | Earliest date for advance notice of stockholder proposals for 2027 Annual Meeting (other than Rule 14a-8 proposals). |
| 2027-02-04 | Latest date for advance notice of stockholder proposals for 2027 Annual Meeting (other than Rule 14a-8 proposals). |
| 2027-05-01 | Anticipated month for 2027 Annual Meeting. |
| 2028-01-01 | Expected next advisory vote on executive compensation. |
| 2029-02-15 | End of quarterly vesting for annual RSUs granted to NEOs in March 2025. |
| 2029-05-15 | End of quarterly vesting for additional RSUs granted to Mr. Nonko in July 2025. |
Recommendation
holdThe company demonstrates strong growth in its P&C insurance vertical and overall financial metrics, indicating a healthy core business. However, the decline in the health insurance vertical and the significant legal expenses related to the FTC enforcement action introduce considerable uncertainty and potential future headwinds. While corporate governance improvements and executive compensation alignment are positive, the unresolved regulatory matter and its 'undetermined but significant impact' warrant a cautious 'hold' stance until there is greater clarity on its resolution and financial implications.
Keywords
MediaAlpha, Proxy Statement, Annual Meeting, Corporate Governance, Director Election, Auditor Ratification, Executive Compensation, Financial Performance, Transaction Value, Adjusted EBITDA, Net Income, PricewaterhouseCoopers LLP, FTC Enforcement, Tax Receivables Agreement, Stockholder Vote, Equity Awards, RSUs, PRSUs, Board of Directors, Risk Management, Share Repurchase, Health Insurance, P&C Insurance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.